Allergic bronchopulmonary aspergillosis (ABPA) is an immunologic pulmonary disorder
caused by hypersensitivity to Aspergillus fumigatus. Clinically, a patient presents with
chronic asthma, recurrent pulmonary infiltrates, and bronchiectasis. The population
prevalence of ABPA is not clearly known, but the prevalence in asthma clinics is reported to
be around 13%. The disorder needs to be detected before bronchiectasis has developed
because the occurrence of bronchiectasis is associated with poorer outcomes. Because …